The Price Target For Curis Inc. (CRIS)?


Curis Inc. (NASDAQ:CRIS) traded with a subtraction of $0.0 to $0.78 on Thursday, a downside of -0.35 percent. An average of 1,100,215 shares of common stock have been traded in the last five days. There was a fall of -$0.1301 in the past week, and it reached a new high 2 times over the past 12 months. The last 20 days have seen an average of 1,606,444 shares traded, while the 50-day average volume stands at 3,170,368.

CRIS stock has decreased by -28.87% in the last month. The company shares reached their 1-month lowest point of $0.7600 on 09/21/22. With the stock rallying to its 52-week high on 01/05/22, shares of the company touched a low of $0.70 and a high of $8.50 in 52 weeks. It has reached a new high 3 times so far this year and lost -83.56% or -$3.9812 in price. In spite of this, the price is down -90.83% from the 52-week high.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.


Insider Transactions

234 days have passed since Curis Inc. (CRIS) last reported insider trading activity. Dentzer James E, who is President & CEO, most recently acquired $3,094 shares at $3.07 per share on Jan 31. In this transaction, the insider spent $9,499. President & CEO, Dentzer James E, disposed of 2,406 shares at a price of $3.18 on Jan 27. The insider now owns more than $7,651 worth of shares.

Valuation Metrics

Curis Inc. (CRIS) stock’s beta is 2.69. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 6.99, the price-to-book (PB) ratio at 1.15.

Financial Health

The quick ratio of Curis Inc. for the three months ended June 29 was 9.30, and the current ratio was 9.30, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the quarter ending June 29. Its gross profit as reported stood at $10.12 million compared to revenue of $10.65 million.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Curis Inc.’s return on assets was -37.60%.

Earnings Surprise

For the three-month period that ended June 29, Curis Inc. had $73.19 million in cash. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$15.94 million in the quarter, while revenues of -$16.11 million were grew 31.99%. The analyst consensus anticipated Curis Inc.’s latest quarter earnings to come in at -$0.17 per share, but it turned out to be -$0.17, a 0.00% surprise. For the quarter, EBITDA amounted to -$14.44 million. Shareholders own equity worth $91.81 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Curis Inc. (CRIS) price momentum. RSI 9-day as of the close on 21 September was 29.50%, suggesting the stock is oversold, with historical volatility in this time frame at 49.45%.

As of today, CRIS’s price is $0.8114 -14.31% or -$0.1301 from its 5-day moving average. CRIS is currently trading -27.21% lower than its 20-day SMA and -14.76% lower than its 100-day SMA. However, the stock’s current price level is -34.55% below the SMA50 and -83.46% below the SMA200.

The stochastic %K and %D were 6.56% and 6.86%, respectively, and the average true range (ATR) was 0.0706. With the 14-day stochastic at 6.84% and the average true range at 0.0814, the RSI (14) stands at 34.99%. The stock has reached -0.0835 on the 9-day MACD Oscillator while the 14-day reading was at -0.1094.

Analyst Ratings

Raymond James downgraded Curis Inc. (NASDAQ: CRIS) to a a Mkt perform rating in its most recent analyst report. Previously, the stock was rated as an Outperform. The consensus rating for Curis Inc. (CRIS) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell CRIS, while 1 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 4 others rate it as a “buy”.


Please enter your comment!
Please enter your name here